Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Sareum Holdings PLC on Tuesday said it is excited about the future of its potential new therapeutic for autoimmune di ...
Sareum Holdings PLC 29 October 2024 Sareum Holdings PLC ("Sareum" or the "Company") Final Results for the Year Ended 30 June 2024 Cambridge, UK, 29 October 2024 - Sareum Holdings plc (AIM:...
Sareum Holdings PLC 23 October 2024 Sareum Holdings PLC ("Sareum" or the "Company") Notice of Final Results for the Year Ended 30 June 2024 and Investor Presentation Cambridge, UK...
LC - Cambridge, England-based pharmaceutical company focused on developing next-generation kinase inhibitors for autoi ...
Sareum Holdings PLC 21 October 2024 THIS ANNOUNCEMENT (THE "ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR...
Sareum Holdings PLC on Friday said that it has completed a fundraise of GBP2.4 million before expenses via a subscrip ...
Sareum Holdings PLC 11 October 2024 THIS ANNOUNCEMENT (THE "ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR...
Sareum Holdings PLC on Monday announced it has received a patent allowance for the development of crystalline forms o ...
Sareum Holdings PLC 16 September 2024 Sareum Holdings plc ("Sareum" or the "Company") Patent Allowance for Crystalline Forms of SDC-1801 in China Cambridge, UK, 16 September 2024 - Sareum...
Sareum Holdings PLC 02 September 2024 Sareum Holdings plc ("Sareum" or the "Company") US patent allowance for its lead programme SDC-1801 - Notice of Allowance from US Patent and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 8.16326530612 | 24.5 | 27.25 | 24.5 | 547879 | 25.95188007 | DE |
| 4 | 2.5 | 10.4166666667 | 24 | 27.25 | 23.5 | 407056 | 25.29077831 | DE |
| 12 | -2 | -7.01754385965 | 28.5 | 32 | 21 | 354131 | 26.29661597 | DE |
| 26 | -9 | -25.3521126761 | 35.5 | 52.5 | 21 | 394202 | 32.97212648 | DE |
| 52 | -36 | -57.6 | 62.5 | 75 | 10.2 | 608691 | 27.19416714 | DE |
| 156 | -201 | -88.3516483516 | 227.5 | 337.5 | 10.2 | 1317259 | 197.25839598 | DE |
| 260 | 8 | 43.2432432432 | 18.5 | 487.5 | 10.2 | 9184109 | 143.64256662 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
